SMS Lifesciences India Ltd: A Snapshot of the Company’s Current Standing
SMS Lifesciences India Limited, a prominent player in the healthcare sector, specializes in the manufacturing of active pharmaceutical ingredients (API) and their intermediates. The company is listed on the National Stock Exchange of India and operates primarily in the pharmaceutical industry. As of July 10, 2025, the close price of SMS Lifesciences stood at 1,157.1 INR, with a market capitalization of 3,580,000,000 INR. The company’s price-to-earnings ratio is currently 17.78.
Product Portfolio
The company’s API products include a diverse range of pharmaceuticals such as Ranitidine Hydrochloride, Famotidine, Sildenafil Citrate, Allopurinol, Ropivacaine Hydrochloride, Dapsone, Sibutramine Hydrochloride, Itraconazole, Fosphenytoin Sodium, Domperidone, Brinzolamide, Tiagabine, Fosaprepitant, and Albendazole. In addition to these, SMS Lifesciences also manufactures intermediates like Ranitidine HCl Intermediates, Rizatriptan Intermediates, and Imidapril Intermediates.
Manufacturing and R&D Facilities
The company’s manufacturing facilities are strategically located at Kazipally and Jeedimetla, while its research and development center is situated in Sanath Nagar, Hyderabad. These locations support the company’s robust production and innovation capabilities.
Subsidiary
SMS Lifesciences India Limited has a wholly owned subsidiary, Mahi Drugs Private Limited, which contributes to its overall business operations.
Market Performance
Over the past year, the company’s stock has experienced significant fluctuations. The 52-week high was recorded at 1,749.65 INR on September 8, 2024, while the 52-week low was 815 INR on July 21, 2024. These figures reflect the dynamic nature of the pharmaceutical market and the company’s position within it.
In summary, SMS Lifesciences India Limited remains a key player in the pharmaceutical industry, with a strong focus on API and intermediate manufacturing, supported by its strategic facilities and subsidiary operations.